Overview of the six original ACTIV-3/TICO trials. by Elizabeth S. Munroe (21568166)

Subjects:

Data from: Colony losses of stingless bees increase in agricultural areas, but decrease in forested areas by Malena Sibaja Leyton (18400983)

“…Moreover, annual colony losses also decreased with higher abundance of surrounding forested area. …”

Baseline patient characteristics. by Oscar F. C. van den Bosch (22184246)

“…In contrast, s-ketamine largely preserved respiratory variability, suggesting it may be a safer alternative for sedation in patients with impaired spontaneous breathing. Further studies are needed to assess the clinical implications of these observations in patients undergoing sedation.…”

ONSD at T14 and six months after ICU discharge. by Marco Carbonara (11483575)

Subjects:

Baseline patient characteristics across neutralizing monoclonal antibody trials. by Elizabeth S. Munroe (21568166)

Subjects:

Long-term anti-nucleocapsid response by baseline patient characteristics. by Elizabeth S. Munroe (21568166)

Subjects:

Experiences of conducting six-monthly multi-month refills as scored by healthcare workers. by Rachel Chamanga (14492705)

Subjects:

Socio-demographic characteristics of hypertensive patients’ caregivers (n = 422). by Chikondi Maluwa (20660522)

Subjects:

Average Gait Speed (A), Cadence (B), Step Length (C), and Walk Ratio (D) across Terrains; Violin plots with individual participant data of A) gait speed, B) cadence, C) average ste... by Benjamin S. Killen (22766029)

Subjects:

Diagram of Outdoor Terrains; Participants performed two loops (clockwise and counterclockwise). by Benjamin S. Killen (22766029)

Subjects:

Results of Multiple Linear Regression. by Benjamin S. Killen (22766029)

Subjects:

Spatiotemporal Gait Parameters Across Terrains. by Benjamin S. Killen (22766029)

Subjects:

Participant Demographic Information. by Benjamin S. Killen (22766029)

Subjects:

Level classification and summary of total scores of KAP towards hypertension among caregivers at baseline assessment and at week six assessment (n = 422). by Chikondi Maluwa (20660522)

Subjects:

Patient demographics. by Yongwoo Lee (2265172)

Subjects:

Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for nMAbs, among patients alive and with day 90 antibody and antigen measures (Sensitivity Analysis). by Elizabeth S. Munroe (21568166)

Subjects:

Percentage of positive responses to overall satisfaction 2011/12 by A) Age and sex B) SIMD decile C) Number of Health Issues and D) Urban/Rural Class. by David Henderson (4612354)

Subjects:

Percentage of positive responses to access question 2011/12 by A) Age and sex B) SIMD decile C) Number of Health Issues and D) Urban/Rural Class. by David Henderson (4612354)

Subjects:

Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for neutralizing monoclonal antibodies, among patients alive and with day 90 antibody and antigen measu... by Elizabeth S. Munroe (21568166)

Subjects:

Pearson correlation test, correlations between KAP and correlations between age and KAP at baseline and six weeks post-health education (n = 422). by Chikondi Maluwa (20660522)

Subjects: